Breast vascularity plays a crucial role in both physiological and pathological processes, particularly in the development and progression of breast cancer. Understanding vascular changes within breast tissue is essential for accurate diagnosis, treatment planning, and monitoring therapeutic response. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) has emerged as a valuable tool for evaluating breast vascularity due to its ability to provide detailed functional and morphological insights. DCE-MRI utilizes contrast agents to highlight blood flow and vessel permeability, making it especially useful in differentiating between benign and malignant lesions. This review explores the significance of DCE-MRI in breast vascularity assessment, highlighting its principles, clinical applications, and role in detecting malignancy through vascular changes. We also examine its utility in monitoring treatment response and quantitative analysis of perfusion metrics such as Ktrans and extracellular-extravascular volume (Ve). While DCE-MRI offers remarkable diagnostic accuracy, challenges remain regarding its cost, accessibility, and potential overlap of enhancement patterns between benign and malignant conditions. The review further discusses emerging technologies and future directions for DCE-MRI, including advanced imaging techniques and machine learning-based quantification. Overall, DCE-MRI stands out as a powerful tool in the comprehensive evaluation of breast vascularity, with significant potential to improve patient outcomes in breast cancer management.
Keywords: breast cancer imaging; breast vascularity; dynamic contrast-enhanced mri (dce-mri); perfusion analysis; treatment response monitoring; tumor angiogenesis.
Copyright © 2024, Sachani et al.